EZH2 Inhibition in Ewing Sarcoma Upregulates G(D2) Expression for Targeting with Gene-Modified T Cells

Chimeric antigen receptor (CAR) engineering of T cells allows one to specifically target tumor cells via cell surface antigens. A candidate target in Ewing sarcoma is the ganglioside G(D2), but heterogeneic expression limits its value. Here we report that pharmacological inhibition of Enhancer of Ze...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther
Main Authors: Kailayangiri, Sareetha, Altvater, Bianca, Lesch, Stefanie, Balbach, Sebastian, Göttlich, Claudia, Kühnemundt, Johanna, Mikesch, Jan-Henrik, Schelhaas, Sonja, Jamitzky, Silke, Meltzer, Jutta, Farwick, Nicole, Greune, Lea, Fluegge, Maike, Kerl, Kornelius, Lode, Holger N., Siebert, Nikolai, Müller, Ingo, Walles, Heike, Hartmann, Wolfgang, Rossig, Claudia
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Gene & Cell Therapy 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6520468/
https://ncbi.nlm.nih.gov/pubmed/30879952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2019.02.014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados